Since 2021, various associations and health experts have been warning of a worrying increase in the incidence of several diseases: atypical cancers, neurological disorders, autoimmune diseases and heart disease. While some hospital departments have noticed this increase, they are reluctant to talk about it publicly. The available data speak for themselves. Reports indicate that COVID-19 vaccines account for 12% of global pharmacovigilance, and nearly 12,000 studies are currently underway to investigate possible links to various diseases. In France, the National Agency for the Safety of Medicines recorded no less than 193,934 reports of adverse reactions, including 1,635 deaths, in its June 2023 report. These figures, based on a passive pharmacovigilance system, probably significantly underestimate the reality, according to many observers.
This situation raises fundamental questions about the transparency of health authorities and the benefit-risk ratio of these hastily developed vaccines. A document published by Pfizer under legal pressure finally offers a more complete view of the risks faced by the millions of people vaccinated around the world.
